Airways, pathogens, innate immunity
11 – 20 of 32
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Isolated anti-HBc : reflections from clinical microbiology and infectious diseases
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Treatment outcome with pencillin G or cloxacillin in penicillin susceptible Staphylococcus aureus bactearemi
(
- Contribution to journal › Article
- 2021
-
Mark
Divergent airway microbiomes in lung transplant recipients with or without pulmonary infection
(
- Contribution to journal › Article
-
Mark
Citrullination of extracellular histone H3.1 reduces antibacterial activity and exacerbates its proteolytic degradation
(
- Contribution to journal › Article
-
Mark
Endocarditis due to Staphylococcus lugdunensis—a retrospective national registry–based study
(
- Contribution to journal › Article
-
Mark
Complex Involvement of Interleukin-26 in Bacterial Lung Infection
(
- Contribution to journal › Article
-
Mark
Genomic and phenotypic evolution of achromobacter xylosoxidans during chronic airway infections of patients with cystic fibrosis
(
- Contribution to journal › Article
-
Mark
Distinct phenotypes of platelet, monocyte, and neutrophil activation occur during the acute and convalescent phase of COVID-19
(
- Contribution to journal › Article
- 2020
-
Mark
Respiratory adenovirus infections in immunocompetent and immunocompromised adult patients
(
- Contribution to journal › Article
-
Mark
Commercial albumin solution enhances endotoxin-induced vasoplegia and inflammation
(
- Contribution to journal › Article